Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings

PURPOSE: To compare the diurnal intraocular pressure (IOP)-lowering effect of latanoprostene bunod (LBN) 0.024% with timolol maleate 0.5% in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT). PATIENTS AND METHODS: Pooled analysis of two phase 3, randomized, multicenter, double-mas...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Glaucoma
Asıl Yazarlar: Weinreb, Robert N., Liebmann, Jeffrey M., Martin, Keith R., Kaufman, Paul L., Vittitow, Jason L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer Health, Inc 2018
Konular:
Original Studies
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7654727/
https://ncbi.nlm.nih.gov/pubmed/29194198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IJG.0000000000000831
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller